1. Home
  2. EHC vs DVA Comparison

EHC vs DVA Comparison

Compare EHC & DVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EHC
  • DVA
  • Stock Information
  • Founded
  • EHC 1983
  • DVA 1994
  • Country
  • EHC United States
  • DVA United States
  • Employees
  • EHC N/A
  • DVA N/A
  • Industry
  • EHC Hospital/Nursing Management
  • DVA Misc Health and Biotechnology Services
  • Sector
  • EHC Health Care
  • DVA Health Care
  • Exchange
  • EHC Nasdaq
  • DVA Nasdaq
  • Market Cap
  • EHC 12.3B
  • DVA 10.9B
  • IPO Year
  • EHC 1986
  • DVA 1995
  • Fundamental
  • Price
  • EHC $118.48
  • DVA $142.58
  • Analyst Decision
  • EHC Strong Buy
  • DVA Hold
  • Analyst Count
  • EHC 8
  • DVA 4
  • Target Price
  • EHC $123.38
  • DVA $157.00
  • AVG Volume (30 Days)
  • EHC 714.7K
  • DVA 852.9K
  • Earning Date
  • EHC 08-04-2025
  • DVA 08-05-2025
  • Dividend Yield
  • EHC 0.58%
  • DVA N/A
  • EPS Growth
  • EHC 30.58
  • DVA 14.90
  • EPS
  • EHC 4.84
  • DVA 10.11
  • Revenue
  • EHC $5,512,600,000.00
  • DVA $12,968,524,000.00
  • Revenue This Year
  • EHC $10.73
  • DVA $6.46
  • Revenue Next Year
  • EHC $8.61
  • DVA $3.24
  • P/E Ratio
  • EHC $24.17
  • DVA $14.11
  • Revenue Growth
  • EHC 11.21
  • DVA 5.11
  • 52 Week Low
  • EHC $82.74
  • DVA $131.76
  • 52 Week High
  • EHC $123.13
  • DVA $179.60
  • Technical
  • Relative Strength Index (RSI)
  • EHC 46.44
  • DVA 54.05
  • Support Level
  • EHC $116.39
  • DVA $139.55
  • Resistance Level
  • EHC $120.35
  • DVA $145.88
  • Average True Range (ATR)
  • EHC 1.93
  • DVA 3.32
  • MACD
  • EHC -0.50
  • DVA 0.29
  • Stochastic Oscillator
  • EHC 31.54
  • DVA 60.43

About EHC Encompass Health Corporation

Encompass Health Corp provides post-acute healthcare services in the United States through a network of inpatient rehabilitation hospitals. Inpatient rehabilitation contributes the majority of the firm's revenue and provides specialized rehabilitative treatment through a network of inpatient hospitals. These hospitals are concentrated in the eastern half of the United States and Texas.

About DVA DaVita Inc.

DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business. Berkshire Hathaway owns about 45% of DaVita.

Share on Social Networks: